Yeast Infection Market is expected to reach USD 6.23 billion by 2029

Market Analysis and Size

Surging cases of the yeast infection is estimated to drive the market's growth across the globe. According to NCBI studies, in 2018, around 30%-50% of women had vulvovaginal candidiasis at least once in their lives. Moreover, in Asia Pacific, Candida species is the most frequent yeast infection. Consequently, the market is estimated to show substantial growth over the forecasted period.

Global Yeast infection Market was valued at USD 3.88 billion in 2021 and is expected to reach USD 6.23 billion by 2029, registering a CAGR of 6.10% during the forecast period of 2022-2029. The "bacterial" accounts for the largest pathogen segment in the yeast infection market within the forecasted period owing to the rise in the bacterial yeast infection cases and the rising prevalence of HAIs. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Read More :
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market

Market Definition

Candidiasis, often known as yeast or fungus infection, is a parasitic ailment. It's a naturally occurring component in the human body. It can cause infection in some cases due to changes in the body's immune level. It can also affect the skin, mouth, and stomach. Yeast infection in the vaginal area is very prevalent among women. Rashes, swelling, redness, stinging, and burning are all symptoms of this infection. Yeast infection can be caused by a lack of immunity, poor cleanliness, or lifestyle disorders.

Competitive Landscape and Yeast infection Market Share Analysis
The yeast infection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to yeast infection market.

Some of the major players operating in the yeast infection market are

Scynexis Inc., (U.S.)
Merck & Co., Inc. (U.S.)
Bayer AG (Germany)
Astellas Pharma Inc., (Japan)
Thermo Fisher Scientific Inc., (U.S.)
Novartis AG (Switzerland)
Abbott (U.S.)
Catalent, Inc., (U.S.)
bioMérieux (France)
Pfizer Inc. (U.S.)
AbbVie Inc., (U.S.)
ALLERGAN (Ireland)
Jubilant Pharmova Limited (India)
Sanofi (France)
AstraZeneca (U.K)
Bruker (U.S.)
Brundavan Laboratories Ltd. (India)
Curia Global, Inc. (U.S.)
Corden Pharma (Germany)

More Links:

https://dbmrbuisness.blogspot.com/2023/07/analytical-chromatography-in-pharma.html

https://dbmrbuisness.blogspot.com/2023/07/global-protein-crystallization-and.html

https://dbmrbuisness.blogspot.com/2023/07/global-antidepressants-market-industry.html

https://dbmrbuisness.blogspot.com/2023/07/global-non-cardioselective-beta.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.